Skip to content

The application of Baha Attract system in chronic suppurative otitis media

The application of Baha Attract system in chronic suppurative otitis media

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064510
Enrollment
Unknown
Registered
2022-10-10
Start date
2022-10-05
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic suppurative otitis media

Interventions

Group 1 :Baha Attract Implantation

Sponsors

Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 or above; 2. The ear to be implanted suffers from chronic suppurative otitis media: unilateral or bilateral conductive hearing loss; or mixed hearing loss accompanied by sensorineural hearing loss not exceeding 55 dB, that is, the mean bone conduction pure tone hearing threshold PTA4 is less than or equal to 55 dBHL (the average value measured at 500 Hz, 1000 Hz, 2000 Hz and 4000 Hz); 3. Relevant medical history (meeting one of the conditions): otitis media patients with unsatisfactory hearing after conventional middle ear surgery; otitis media patients with unsatisfactory hearing aid effect after wearing air conduction hearing aids; otitis media patients with intolerance to wearing conventional air conduction hearing aids.

Exclusion criteria

Exclusion criteria: 1. A suitable implant site for BI300 implant (4 mm or 3 mm) could not be found during surgery due to insufficient bone mass or thickness; 2. The soft tissue thickness of the planned implantation site is less than 3 mm; 3. Existing physical conditions requiring frequent magnetic resonance imaging (MRI) examinations; 4. Subject has any physical conditions that, in the judgment of the investigator, may jeopardize osseointegration and/or wound healing (e.g. osteoporosis, psoriasis, long-term corticosteroid use, etc.); 5. Subjects had uncontrolled diabetes, as judged by the researchers; 6. According to the judgment of the investigator, the subject has a condition that may affect the results of the study, such as retrocochlear lesions; 7. The subject has participated in the study using other drugs or medical devices; 8. Subjects had unrealistic expectations about the benefits, risks, and limitations of the surgery and implanted devices.

Design outcomes

Primary

MeasureTime frame
Hearing evaluation (the ear with or without surgery);

Secondary

MeasureTime frame
Quality of Life;Skin tolerance;Imolant tolerance;Discharging situation of the ear with surgery;

Countries

China

Contacts

Public ContactGuangxia Xiong

Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University

xguanx@mail.sysu.edu.cn+86 13802988177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026